Transrepression of NF-κB is not required for glucocorticoid-mediated protection of TNF-α-induced apoptosis on fibroblasts  by Costas, Mónica A. et al.
Transrepression of NF-UB is not required for glucocorticoid-mediated
protection of TNF-K-induced apoptosis on ¢broblasts
Mo¤nica A. Costas a;1, Lionel Mu«ller Igaz a, Florian Holsboer b, Eduardo Arzt a;1;*
a Laboratorio de Fisiolog|¤a y Biolog|¤a Molecular, Departamento de Ciencias Biolo¤gicas, Facultad de Ciencias Exactas y Naturales,
Universidad de Buenos Aires, Ciudad Universitaria, Pabello¤n II, C1428EHA Buenos Aires, Argentina
b Max-Planck Institute of Psychiatry, Kraepelinstrasse 2^10, 80804 Munich, Germany
Received 6 June 2000; received in revised form 27 September 2000; accepted 10 October 2000
Abstract
The cellular resistance to tumor necrosis factor (TNF) of most cell types has been attributed to both a protective pathway
induced by this cytokine and the preexistence of protective factors in the target cell. NF-UB has been postulated as one of the
principal factors involved in antiapoptotic gene expression control on TNF-resistant cells. We have previously shown that
glucocorticoids protect the naturally TNF-sensitive L-929 cells from apoptosis. Here we analyze the role of NF-UB and
glucocorticoids on TNF-induced apoptosis in L-929 cells. We found that inhibition of NF-UB enhanced the sensitivity to
TNF-induced apoptosis. Glucocorticoids inhibited NF-UB transactivation via IUB induction. Moreover, glucocorticoids
protected from TNF-induced apoptosis even when NF-UB activity was inhibited by stable or transient expression of the
superrepressor IUB. These results demonstrate that although glucocorticoids inhibit NF-UB transactivation in these cells, this
is not required for their protection from TNF-induced apoptosis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Most normal and neoplastic cell types are resistant
to tumor necrosis factor (TNF) cytotoxicity unless
they are sensitized with protein or RNA synthesis
inhibitors, such as cycloheximide or actinomycin D
[1]. The cellular resistance has been attributed to a
molecular mechanism by which TNF exerts on the
target cell two signals: one of them opens the door to
cell death, while the other, that requires the novo
synthesis of proteins, involves a protective pathway
as well as the preexistence of cellular factors that can
suppress the apoptotic stimulus generated by TNF
[2^6].
TNF p55 is the main receptor on most cell types
and after TNF binding, the activation occurs
through a trimerization [7,8] and recruitment of oth-
er proteins such as TNF receptor-associated death
domain (TRADD), TNF receptor-associated factor
2 (TRAF2) and receptor-interacting protein (RIP)
to the p55 cytoplasmic death domain [9^11].
TRADD acts as an adapter that recruits the down-
stream transducer Fas-associated death domain-con-
taining protein (FADD) and activates the apoptotic
caspases, while TRAF2 has been implicated in the
activation of two distinct pathways that lead to the
activation of AP-1 via the c-Jun amino terminal
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kinases (JNKs) and, together with RIP, NF-UB acti-
vation, via the NF-UB-inducing kinase (NIK) [3].
Although there is some controversy about the role
of these transcription factors in apoptosis, most evi-
dence supports an antiapoptotic action for both on
TNF-induced apoptosis [2]. In the case of NF-UB,
some authors have shown that cells that are naturally
resistant to TNF-induced apoptosis became sensi-
tized when they are transfected with an expression
vector for IUB, that keeps NF-UB inactive [12,13].
We and others have previously described a model
where glucocorticoids prevent TNF-K induced cell
death of mouse ¢broblast L-929 cells [14,15], the op-
posite e¡ect that they have in other cells, such as NK
cells [16] where they induce apoptosis, having a dual
role in neurons [17] or lymphocytes [18] depending
on the stimulus. In addition, cells that are sensitive to
glucocorticoid-induced apoptosis may be rescued
from death by cytokines [17,19]. At least in part
the interaction of glucocorticoids and cytokines is
supported by the hypothesis of mutual antagonistic
actions between the glucocorticoid receptor (GR)
and NF-UB. The molecular mechanism by which glu-
cocorticoids antagonize biological function of cyto-
kines is now clearly explained through at least two
di¡erent, but not opposite, pathways [20]. One of
them involves physical interaction between GR and
NF-UB or AP-1 which leaves both GR and the tran-
scription factor inactive on the cytoplasm [21]. The
other mechanism is the induction of IUB by gluco-
corticoids [22,23], although there are some cell lines
were it does not occur [24].
In this work we analyze the role of NF-UB and its
interaction with GR in the model of L-929 cells,
which normally die after TNF-K treatment and are
protected by glucocorticoids.
2. Materials and methods
2.1. Cells and reagents
The mouse ¢broblast cell line L-929 was grown in
Dulbecco’s modi¢ed Eagle’s medium (DME) (Gibco,
Grand Island, NY, USA) supplemented with 10%
charcoal stripped steroid-free fetal calf serum (FCS)
(Gibco, Paisley, UK), penicillin (100 units/ml) and
streptomycin (100 mg/ml). The cells were maintained
at 37‡C in a humidi¢ed atmosphere of 5% CO2. Un-
less stated otherwise, reagents were from Sigma (St.
Louis, MO, USA) or Pharmacia (Uppsala, Sweden).
2.2. Expression vectors and reporter plasmids
UB-Luc vector (UB sites from HIV promoter) was
kindly provided by Dr. M. Bell (Mayo Clinic, Ro-
chester, MN, USA), CMV-L-galactosidase (L-gal)
was kindly provided by Dr. D. Spengler (Max-
Planck Institute of Psychiatry, Munich, Germany).
ssIUB (a superrepressor IUB) contains a mutated
site at Ser 32 and Ser 36 which impedes phosphory-
lation and proteolysis and was kindly provided by
Dr. B. Kaltschmidt (Univ. Freiburg, Germany).
2.3. Transfections and assays of luciferase and
L-galactosidase activities
Transfection and reporter determination were per-
formed as previously described [15,25].
The L-929 cell line was transfected using lipofect-
amine (Gibco, Grand Island, NY, USA). Brie£y,
cells were cultured in plates of six wells (3U105
cells/well) in DME without serum and antibiotics
and transfected with 2 Wg of DNA. In all cases cells
were co-transfected with the constitutive L-gal ex-
pression vector. After 5 h medium was removed
and replaced by fresh DME with 10% charcoal
stripped serum. For transient transfections and stud-
ies of UB-Luc activity, cells were stimulated with hu-
man TNF-K (Research and Diagnostic Systems,
Minneapolis, MN, USA) and/or dexamethasone
(DEX) 1 h after addition of new fresh medium, dur-
ing 24 h. Cellular extracts for Luc and L-gal assays
were made using a lysis bu¡er (Promega, Madison,
WI, USA). Relative luminescence units (RLU) were
measured in a Junior luminometer (EG and Bert-
hold, Germany). For cytotoxicity assays, transiently
transfected cells were replated on £at bottom 96-well
plates and then stimulated with TNF and/or DEX as
described above.
Stable ssIUB expressing clones were selected by G-
418 (Gibco, Paisley, UK) 400 Wg/ml and maintained
with 200 Wg/ml of this antibiotic. The functional role
of ssIUB on stable expression was veri¢ed analyzing
UB-Luc activity in response to di¡erent doses of
TNF. No Luc induction was observed at any dose
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of TNF, being similar to basal Luc activity, in the
absence of TNF.
2.4. Determination of IUB mRNA
Northern blot was performed as previously de-
scribed [15]. Brie£y, total RNA, isolated by the gua-
nidine isothiocyanate phenol-chloroform extraction
method, was denatured with glyoxal, electrophoresed
on a 1.2% agarose gel and transferred overnight to a
nylon membrane. Filters were baked for 2 h at 80‡C
and stained with methylene blue. They were prehy-
bridized for 4 h at 45‡C (50% formamide, 5USSPE,
5UDenhardt’s solution, 0.1% SDS, 100 mg/ml dena-
tured salmon sperm DNA) and then the probe was
added for 12 h. Blots were washed at increasing salt
and temperature stringency with a ¢nal wash of 30
min at 45‡C in 0.1USSC containing 0.1% SDS.
Dried ¢lters were exposed to Kodak XAR5 ¢lm at
370‡C with intensifying screens for 2 days. The blots
were reprobed after eluting the ¢rst probe with 5 mM
Tris-HCl pH 8.0, 2 mM EDTA, 0.1UDenhardt’s
solution, at 65‡C for 2 h. The 0.970 kb IUB [26]
and 6.6 kb EcoRI fragment of a 28S and part of
18S mouse cDNA [27] cDNA probes (speci¢c activ-
ity, 2^4U108 cpm/mg) were labeled with a random-
priming kit using [K-32P]dCTP. The control with the
ribosomal 28S cDNA as probe was performed in
each blot.
2.5. Cytotoxicity assay and pharmacological
inhibitors
In order to determine the role of NF-UB on p55
TNF receptor-induced cell death, non-transfected
mouse ¢broblast L-929 cells were plated at 3U105
cells/well in 96-well microtiter plates in the presence
of di¡erent doses of hTNF-K, which is know to bind
the mouse p55 receptor [28], in the absence or the
presence of di¡erent doses of pyrrolidine dithiocar-
bamate (PDTC), a metal chelator which inhibits ROI
generation as NF-UB induction [29] or sulfasalazine
[30] and DEX for 20 h. Plates were stained with 0.5%
crystal violet in 70% methanol, and then washed and
resuspended in acetic 33% solution; the absorbance
was determined at 570 nm.
Some cultures were stained with acridine orange
and ethidium bromide and the morphology of death
and surviving cells was observed at £uorescent mi-
croscopy, con¢rming, as previously shown [15], that
the cell death induced by TNF-K is apoptotic.
Cells transiently expressing ssIUB or the empty
vector were cultured and stimulated as before (with-
Fig. 1. (A) E¡ect of PDTC on TNF-induced cell death. L-929
cells cultured in 96-well microtiter plates were stimulated simul-
taneously with di¡erent doses of TNF and PDTC, as indicated.
After 20 h monolayers were washed, ¢xed and stained with
70% methanol/0.5% crystal violet. Absorbance of stained surviv-
ing cells was determined at 570 nm. Each value is the average
of triplicate wells. Similar results were obtained in three inde-
pendent experiments. S.D.s are not shown in order to facilitate
the interpretation of the ¢gure, and they are less than 10% for
each point. The same results were obtained when cultures were
stained with acridine orange and ethidium bromide. (B) E¡ect
of sulfasalazine on TNF-induced cell death. L-929 cells cultured
in 96-well microtiter plates were stimulated simultaneously with
di¡erent doses of TNF and sulfasalazine (slz). Cells were ¢xed
and stained as in A. Each value of the diagram bars corre-
sponds to the average þ S.D. of three wells, where the percent-
age of surviving cells was determined with respect to the basal
absorbance (cells without treatment). Similar results were ob-
tained in three independent experiments.
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out PDTC or sulfasalazine) and then, non-adherent
dead cells were removed and monolayers of surviving
cells were ¢xed with 0.02% of paraformaldehyde and
stained with the L-galactosidase substrate x-gal. At
least two wells of blue cells were counted for each
treatment. Percentage of cytotoxicity was determined
with respect to the total blue cells of basal cultures
(without any treatment).
2.6. Statistical analysis
Statistics were performed using one- and two-fac-
tor ANOVA in combination with Fisher and Schef-
fe’s tests.
3. Results
3.1. Inhibition of NF-UB activity increases the
sensitivity to TNF-K-induced cell death
A pharmacological approach was performed in or-
der to determine the role on NF-UB on TNF-induced
cell death in L-929 cells. As shown in Fig. 1A, all the
doses employed of the NF-UB inhibitor PDTC in-
creased TNF-induced cell death at all the TNF-K
doses employed (Fig. 1A). PDTC alone resulted
Fig. 2. (A) E¡ect of stable ssIUB expression on TNF-induced
cell death. Wild type cells or a stably expressing ssIUB clone
were cultured in 96-well microtiter plates and stimulated with
di¡erent doses of TNF. Cells were ¢xed and stained as in Fig.
1A. Each value is the average of triplicate wells. Similar results
were obtained in three independent experiments. S.D. is less
than 10% for each point. (B) E¡ect of transient expression of
ssIUB on TNF-induced cell death. Cells transfected with CMV-
L-gal plus ssIUB or the empty vector were replated on 96-well
microtiter plates and stimulated with di¡erent doses of TNF.
After 20 h, monolayers of surviving cells where ¢xed and
stained with x-gal. Blue cells were counted by microscopy for
each dose of TNF. Percentage of surviving cells was determined
with respect to the total blue cells in basal conditions. The ¢g-
ure shows the average for each value of four independent ex-
periments, where each experimental point was performed at
least in triplicate. S.D. is less than 10% for each point. For all
conditions, at least P6 0.05 (ANOVA with Fisher’s test). R,
NS.
Fig. 3. E¡ect of transient or stable ssIUB expression on UB-Luc
activity. Cells were transiently co-transfected with a UB-Luc re-
porter plasmid plus CMV-L-gal and the ssIUB or the empty
vector (A). Wild type cells or the IUB clone were co-transfected
with a UB-Luc reporter plasmid plus CMV-L-gal (B). In both
cases cells were stimulated or not with 5 ng/ml of TNF-K. Rela-
tive luminescence units are the average of triplicate þ S.D. and
were normalized with the corresponding L-galactosidase values.
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proapoptotic for this cell line, even at lower doses
than those used by others to inhibit NF-UB [29]
(not shown). Since this e¡ect of PDTC may not
only be due to the inhibition of NF-UB, in similar
experiments cells were treated with di¡erent doses of
sulfasalazine, a more speci¢c inhibitor of NF-UB ac-
tivation [30]. It also increased TNF-induced cytotox-
icity, the action being dose-dependent (Fig. 1B).
A clone of L-929 cells stably expressing ssIUB also
resulted more sensitive to TNF-induced cytotoxicity
than wild type cells, although this was not observed
at the lower doses of TNF (Fig. 2A). The same was
observed with cells transiently transfected with IUB
(Fig. 2B). In addition, in order to prove the e¡ective-
ness of IUB we co-transfected the cells with UB-Luc.
Cells transiently expressing ssIUB and the reporter
plasmid UB-Luc did not show NF-UB activity in
the presence or the absence of TNF treatment (Fig.
3A), but the stable ssIUB clone transiently trans-
fected with the reporter shows a small but detectable
basal NF-UB activity (Fig. 3B).
All together, these experiments indicate that TNF-
induced NF-UB has a protective role on TNF-in-
duced L-929 cell death.
3.2. Glucocorticoids antagonize NF-UB
transactivation via IUB induction
As shown in Fig. 4A, DEX, at doses that protect
from TNF-induced cell death [15], signi¢cantly inhib-
ited basal and TNF-induced NF-UB activity.
Fig. 4B shows the e¡ect of DEX on mRNA ex-
pression for IUB after 3 h of treatment. TNF induced
IUB mRNA and DEX increased IUB mRNA both in
the absence and presence of a cytotoxic dose of
TNF. According to these data, IUB induction by
glucocorticoids may be one mechanism by which
transrepression can occur in these cells.
3.3. Glucocorticoid protection of TNF-induced cell
death does not require NF-UB transrepression
Since glucocorticoids had a protective e¡ect on
TNF-induced cytotoxicity in these cells, they inhib-
Fig. 4. (A) E¡ect of glucocorticoids on TNF-induced NF-UB activity in L-929 cells. Transiently UB-Luc and L-gal co-transfected cells
were stimulated with TNF and/or DEX during 20 h. Relative luminescence units are the average of triplicate þ S.D. and were normal-
ized with the corresponding L-galactosidase values. The conditions BASAL and DEX are not signi¢cantly di¡erent from each other.
Similar results were obtained in three independent experiments. (B) Glucocorticoid action on IUB mRNA levels. Cells were stimulated
for 3 h with 5 Wg of TNF and/or 20 nM of DEX as indicated. Each lane contains 16 Wg of total RNA. Membrane hybridized with
IUB probe was reprobed with the ribosomal 28S probe. Densitometric units relativized (RDU) to 28S ribosomal RNA signal are indi-
cated at the bottom. Similar results were obtained in three independent experiments and also with 10 Wg of TNF and/or 50 nM of
DEX.
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ited NF-UB transactivation and NF-UB inhibition in-
creased cell death, we designed experiments to ana-
lyze the role of NF-UB in the glucocorticoid cytopro-
tection, using cells stably or transiently expressing
ssIUB. As shown in Fig. 5, DEX (20 nM) signi¢-
cantly protected (in the same range) from di¡erent
doses of TNF-induced cell death in both normal cells
(transiently transfected with empty vector) and cells
without induction of NF-UB (transiently transfected
with ssIUB). Similar results were obtained with cells
treated with sulfasalazine and the stable clone ssIUB
(data not shown). These results indicate that the sig-
nal by which glucocorticoids protect from TNF-in-
duced apoptosis does not require NF-UB transrepres-
sion.
4. Discussion
There is evidence showing the pro- or antiapo-
ptotic role of NF-UB in di¡erent cell lines and its
action is controversial [12,13,31]. In di¡erent cell
lines which are resistant to TNF, some authors
have shown that cells with both overexpression of
IUB and downregulation of Rel-A (or double mu-
tants cells Rel-A3=3) become susceptible to TNF-in-
duced cell death [4,12,13]. However, it has not been
described previously which is the role of NF-UB in
cells naturally sensitive to TNF-induced cell death.
In this work we show that overexpression of ssIUB
or downregulation of NF-UB on ¢broblast L-929 en-
hanced the sensitivity to TNF-induced cell death.
These results showing an enhanced TNF-induced ap-
optosis by inhibition of NF-UB activity indicate that
in this cell line, naturally sensitive to TNF-induced
cell death, this transcription factor is not involved in
induction of proapoptotic genes as it is in other mod-
els [32] ; moreover, it has a protective role on signal-
ing to death by the p55 receptor.
Interestingly, the transient expression of ssIUB re-
sulted partially lethal per se, in the absence of TNF,
but we were able to generate a stable clone express-
ing ssIUB and it was not lethal for this cell line.
These observations indicate that either the basal lev-
els of NF-UB activity (Fig. 2B) are su⁄cient or some
unknown mechanisms that compensate the loss of
normal levels of NF-UB may take place on cells sta-
bly downregulating this transcription factor.
Binding of TNF to the p55 receptor results in the
activation of caspase cascades mainly through the
caspase 8 pathway [33]. This mechanism may bypass
the mitochondrial and caspase 9 pathway of cell
death induction. On the other hand, it has been
shown previously that, in L-929 cells, both the gen-
eration of free radicals and mitochondrial damage
play an important role on TNF-induced cell death
[34]. Taking together these observations and our
data, we could hypothesize that NF-UB might have
a protective role only in the caspase 8 pathway, and
thus explain the behavior of these cells in response to
TNF. In other words, L-929 cells might die in re-
sponse to TNF mainly by the mitochondrial pathway
and caspase 9 activation, where NF-UB is not pro-
tective. The increase on cell death by ssIUB could
probably be due to an increase on TNF sensitivity,
because the caspase 8 pathway becomes relevant
when NF-UB is inhibited.
At physiological and molecular levels, almost al-
ways cytokines and glucocorticoids antagonize each
other. The molecular mechanism by which glucocor-
ticoids and cytokines mutually antagonize their func-
tion is explained through at least two di¡erent but
Fig. 5. E¡ect of glucocorticoids on TNF-induced cell death in
ssIUB transiently transfected cells. Transiently IUB expressing
vector (empty symbols) or empty vector (full symbols), and
CMV-L-gal co-transfected cells were replated in 96-well micro-
titer plates and stimulated with di¡erent doses of TNF and
DEX 20 nM. After 20 h, monolayers of surviving cell were
¢xed and stained with x-gal. Percentage of surviving cells was
calculated as in Fig. 2B. Similar results were obtained in three
independent experiments. S.D.s are not shown in order to facili-
tate the interpretation of the ¢gure, and they are less than 10%
for each point. Statistical analysis of the results was performed
by two-way ANOVA with post-hoc Sche¡e’s test. E¡ect of
DEX treatment with ssIUB, F(23,47) = 20.701, P = 0.0001; with-
out ssIUB, F(23, 47) = 11.865, P = 0.0001. The values without
TNF, between equivalent conditions (with or without ssIUB),
are not di¡erent in the presence or the absence of DEX.
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not opposite ways [20]: one of them involves physical
interaction between the glucocorticoid receptor (GR)
and NF-UB [21], and the other the induction of IUB
by glucocorticoids [22,23], although there are some
cell lines were it does not occur. According to our
data, in L-929 cells glucocorticoids antagonize NF-
UB transactivation trough the induction of IUB
mRNA, although we cannot exclude an additional
inhibitory mechanism of interaction between GR
and NF-UB. We have previously shown that in L-
929 cells glucocorticoids do not physically interact
with NF-UB at least until 1 h after treatment [15].
Moreover, priming with low non-cytotoxic doses of
TNF enhances the transcriptional activity of GR via
the GRE [15]. In accordance with this, the same
priming condition enhances the GR-mediated protec-
tion of TNF-induced apoptosis [15], suggesting that
GRE-responsive genes are involved in the protective
action. Here we show that glucocorticoids, 3 h after
treatment, both alone and in combination with a low
cytotoxic dose of TNF enhanced the expression of
IUB mRNA which correlated with glucocorticoid in-
hibition of NF-UB transactivation. It is well known
that glucocorticoids induce apoptosis in di¡erent cell
types whereas cytokines rescue from it [19]. However,
L-929 cells are at present one of the few models
where glucocorticoids protect from TNF-induced ap-
optosis. In addition, this is one of the few cell lines
which are naturally sensitive to TNF. If NF-UB
could have an apoptotic role in this cell line, the
glucocorticoid transrepression of this transcription
factor would be a plausible model to explain its pro-
tective action on TNF-induced cell death. However,
according to our results, glucocorticoid protection
from TNF-induced apoptosis occurs at the same ra-
tio at either normal or low levels of NF-UB induc-
tion. These observations suggest that although GR
and NF-UB mutually antagonize, both trigger surviv-
ing signals in L-929 cells. Thus, glucocorticoids turn
o¡ NF-UB target genes, which protect from a major
death but also induce the expression of GRE target
protective genes.
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